The effect of progesterone in preventing LH surge in IVF cycles

Comparison of progesterone effect in preventing LH surge and quality of oocytes and embryos in IVF cycles with patients undergoing antagonist cycle in Shariati Hospital during 97-98

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200601047630N1

Enrollment

120

Registered

2020-09-18

Start date

2018-03-21

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: On day 2-3 of the gonadotropin cycle, including FSH with or without HMG, with medroxyprogesterone 5 mg daily, two doses are given. Vaginal ultrasounds were performe

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The age between 18 and 35 years ,, a normal sperm test a normal body mass index (18-30 kg / m2) the presence of both ovaries and the opening of the tubes

Exclusion criteria

Exclusion criteria: Tubal factor severe endometriosis hypothalamic amenorrhea oligoasthenospermia (abnormal sperm count and shape) severe uterine anomalies

Design outcomes

Primary

Measure	Time frame
LH surge. Timepoint: End of pregnancy. Method of measurement: blood tests.;Quality of oocyte. Timepoint: End of pregnancy. Method of measurement: Blood tests.;Quality of embryo. Timepoint: End of pregnancy. Method of measurement: Blood tests.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: Day 25 of cycle. Method of measurement: Blood analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Pouri

Tehran University of Medical Sciences

Sarapouri65@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026